Menu

Refactual

We publish EVERYTHING sent to publish@refactual.com

Takeda Ireland Implements Werum’s PAS-X MES, AbbVie’s New RA Drug Wins Approval, and More in Today’s CP Direct!

 

Takeda Ireland Implements Werum’s PAS-X MES, AbbVie’s New RA Drug Wins Approval, and More in Today’s CP Direct!
 Trouble viewing this email? Read it online
Follow us on:       
August 21, 2019
Magazine  I  News  I  Research  I  Directory  I  Topics  I  Classifieds  I  Resources  I  Provider Microsites
Sponsored by Contract Pharma

FEATURED NEWS


Takeda Ireland Implements Werum’s PAS-X MES
Werum’s PAS-X MES automatically pulls manufacturing data from the shop floor by integrating Takeda’s Process Control System
Read More >>

FDA Approves AbbVie’s New RA Drug
Approximately 30 percent of patients treated with RINVOQ achieved clinical remission at week 12 and week 14
Read More >>

Transporters of Emerging Importance: Beyond the Guidance Documents
Transporters discussed in recent FDA and ITC publications, a case study on OCT1 polymorphism effects, Extended Clearance Classification, and transporters in atypical administration routes.
Read More >>

LATEST STORIES


Thermo Fisher Opens VR Training Center in Greenville
Training Center can train 20 people at a time, with the goal of reducing training time by 50%
Read More >>

Emendo Biotherapeutics Achieves Takeda Milestone
Funds will be used to further advance Emendo’s nuclease discovery platform and portfolio development programs
Read More >>

[WEBINAR] Serialization is Behind You – Now What?
Compliance alone can’t solve your drug diversion and counterfeiting problems. Register today for this FREE webinar on September 18th to learn more.
Register Now >>

Marken Expands Services for Home-based Clinical Trials
Direct to patient logistics include clinical drug storage, direct-to-patient delivery, biologic sample collection, central pharmacy and nursing services
Read More >>

ACG Capsules Introduces ACGcaps H+ Capsule Line
Suitable for filling granules, powders, and pellets for prescription and non-prescription pharmaceutical ingredients
Read More >>

Are We Embracing FDA’s Message?
FDA guidance on analytical procedures and methods validation for drugs and biologics.
Read More >>

IBBR Seeks RFPs for cGMP Biologics Manufacturing
Facility is also equipped to perform process development research, preclinical manufacturing for IND-enabling tox studies, Point of Concept studies
Read More >>

   
CURRENT ISSUE
July/August 2019

Latest Issue Check out the feature
content
from the latest issue.

Video Spotlight

 

Pharma Packaging Solutions Expanding Capacity and Services
Investments over $2.7 million were made in several areas including additional portable serialization and aggregation equipment.

Microsite Spotlight

meet-iqvia
Aphena Pharma Solutions, Inc.
Aphena provides customers with a full range of solutions for pharmaceutical manufacturing and packaging requirements. With advanced packaging systems and rigorous cost control, Aphena will deliver solutions that are highly cost effective as well as comprehensive.


We hope you enjoyed this edition of Contract Pharma Direct’s Newsletter

You are receiving this message because you opted in at contractpharma.com. To change your preferences or unsubscribe please use the links below.

To ensure delivery and proper display of your emails, please add our email address (cp@email.contractpharma.com) to your address book and if needed enable images in your email client.

To update your user profile please click here.

To unsubscribe or change your email subscription preferences please click here.

If you are having trouble with receiving Contract Pharma Magazine or would like to receive it, click here.

Advertise with us

Our mailing address is:

Contract Pharma
Rodman Media
25 Philips Parkway, Montvale, NJ 07645 USA
Tel: 201-825-2552, Fax: 201-825-0553

© Copyright 2019 Contract Pharma All rights reserved.


Comments

Like!! Great article post.Really thank you! Really Cool.

Leave a Reply